Preimplantation Genetic Testing Market Players:
- Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer LSDX
- Abbott
- Natera, Inc.
- Yikon Genomics
- Invitae Corporation
- Genea Energy Partners Inc.
- Eurofins Genoma Germany GmbH
- Genomic Prediction
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of preimplantation genetic testing is assessed at USD 930 million.
The global preimplantation genetic testing market size was valued at over USD 858.88 million in 2025 and is expected to expand at a CAGR of more than 9.2%, surpassing USD 2.07 billion revenue by 2035.
North America preimplantation genetic testing market is predicted to capture 38% share by 2035, driven by rising infertility cases and increasing need for bone marrow and organ transplants.
Key players in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer LSDX, Abbott, Natera, Inc., Yikon Genomics, Invitae Corporation, Genea Energy Partners Inc., Eurofins Genoma Germany GmbH, Genomic Prediction.
